| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.043 | 0.4 |